![New Packaging Guidelines for Melatonin Aim to Safeguard Children Against Overdose New Packaging Guidelines for Melatonin Aim to Safeguard Children Against Overdose](https://www.usatoday.com/gcdn/authoring/authoring-images/2024/04/16/USAT/73343316007-getty-images-1352010706.jpg?width=660&height=440&fit=crop&format=pjpg&auto=webp)
The Council for Responsible Nutrition announced new melatonin packaging guidelines Monday, but it will be up to manufactures of the supplements to implement them.
This action taken by the CRN, a leading trade association for the dietary supplement industry, comes after the Centers for Disease Control and Prevention (CDC) put out a report last month stating that nearly 11,000 U.S. children ended up in the emergency room from 2019 and 2022 after ingesting melatonin they took without supervision, USA TODAY previously reported.
In a study published last year, researchers tested 25 melatonin products and found the majority of them were mislabeled. Some were found to contain over 300% more melatonin than what was listed on the bottle.
The new voluntary guidelines are focused on two things: the formulation, labeling and packaging of melatonin-containing dietary supplements and the labeling of gummy dietary supplements, the latter being crucial to the protection of kids.
Here’s exactly what has been proposed.
Melatonin and kids:Many parents give their children melatonin at night. Here’s why you may not want to.
What the new guidelines will include
“These are just the latest in a series of Voluntary Guidelines that CRN members have adopted,” CRN President and CEO, Steve Mister said in a new release. “By setting these high standards, we help our members offer products that are responsibly manufactured and marketed, and widely trusted by consumers.”
The new guidelines are as follows, as presented by the CRN:
Recommendations for melatonin supplements:
- Labeling: Cautionary label statements would alert consumers that melatonin may cause drowsiness, not to take with alcohol, and that the products are intended for intermittent or occasional use only.
- Overages: Any overages of melatonin added during manufacturing would be informed by data to support stability and safety.
- Child deterrent packaging: Child deterrent packaging for products containing melatonin that are in flavored chewable forms especially attractive to children would provide parents a tool to prevent unsupervised access to the products.
Recommendations for gummy form supplements:
- Targeted advisories: Detailed labeling advisories for products aimed at both adults and children would include specific considerations for gummy supplements intended for young children and underscore the importance of using these products under appropriate conditions.
- Avoiding potential choking hazards: For products intended for children under 4 years of age, a precautionary statement would be added to warn against choking if not taken correctly.
- Packaging considerations: Manufacturers would be asked to consider packaging gummy products in containers with child deterrent closures.
The CRN urges its members and the broader industry to adopt these guidelines as soon as possible, the first set within 18 months and the second within 24 months, according to the council.
You can view a complete list of CRN’s Voluntary Guidelines and Best Practices here.
The risk of melatonin gummies for kids
Melatonin in gummy form can be dangerous because it looks and often tastes like candy.
From 2012 to 2021, reports of melatonin ingestion to poison control centers increased 530%, largely occurring among children under age 5, the CDC reported. More than 94% were unintentional.
![Gummy melatonin can be dangerous for kids because it looks like candy.](https://www.usatoday.com/gcdn/media/2022/04/21/USATODAY/usatsports/imageforentry7-jc8.jpg?width=660&height=372&fit=crop&format=pjpg&auto=webp)
Excessive melatonin consumption has not been shown to be fatal, but there is more risk involved when taking higher doses, Dr. Hal Alpert, telemedicine consultant for Blue Sleep, previously told USA TODAY.
Some of the larger risks include rebound insomnia, irritability, depression and sedations that last a couple of days, according to Alpert.
The Food and Drug Administration does not regulate supplements like melatonin.
Contributing: Josie Goodrich and Nada Hassanein